Dr Reddy's Laboratories has launched a new eye drop in the United States. This over-the-counter solution treats itchy eyes.

The Trump administration has finalized a deal with drugmaker AbbVie to cut the cost of certain medicines, marking the latest ...

Dr Reddy's Laboratories launches generic Olopatadine Hydrochloride Ophthalmic Solution for itchy eyes in the US market after ...

Dr Reddy's Laboratories launched a generic OTC ophthalmic solution in the US for relieving itchy eyes, approved by the FDA.

Dr. Reddy's Laboratories announced the launch of over-the-counter (OTC) Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7%, the generic equivalent of Extra Strength Pataday Once-Daily Relief, in ...

Earlier this year, the Trump administration laid off half of SAMHSA staff, terminated $1.7 billion in grants for state health ...

(NYSE: ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, today ...

Dr Reddy’s launches OTC antihistamine eye drops in the US, expanding its eye-care portfolio with FDA-approved Olopatadine solution.

Travere Therapeutics Stock (TVTX) is plummeting on news of a potential FDA delay for its kidney disease treatment ...

Pharma major Dr Reddy’s Laboratories Ltd said on Wednesday, 2025, that it has launched an over-the-counter generic version of ...

Bhopal (Madhya Pradesh): The people associated with the RSS have launched a campaign to stop illegal activities in the state.

Dr. Reddy’s launched Olopatadine Hydrochloride Ophthalmic Solution USP 0.7% (OTC), a generic equivalent of Extra-Strength ...